Literature DB >> 11418131

Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel.

M V Mikhailov1, E A Mikhailova, S J Ashcroft.   

Abstract

We have investigated the structure of the glibenclamide binding site of pancreatic beta-cell ATP-sensitive potassium (K(ATP)) channels. K(ATP) channels are a complex of four pore-forming Kir6.2 subunits and four sulfonylurea receptor (SUR1) subunits. SUR1 (ABCC8) belongs to the ATP binding cassette family of proteins and has two nucleotide binding domains (NBD1 and NBD2) and 17 putative transmembrane (TM) sequences. Co-expression in a baculovirus expression system of two parts of SUR1 between NBD1 and TM12 leads to restoration of glibenclamide binding activity, whereas expression of either individual N- or C-terminal part alone gave no glibenclamide binding activity, confirming a bivalent structure of the glibenclamide binding site. By using N-terminally truncated recombinant proteins we have shown that CL3 - the cytosolic loop between TM5 and TM6 - plays a key role in formation of the N-terminal component of the glibenclamide binding site. Analysis of deletion variants of the C-terminal part of SUR1 showed that CL8 - the cytosolic loop between TM15 and TM16 - is the only determinant for the C-terminal component of the glibenclamide binding site. We suggest that in SUR1 in the native K(ATP) channel close proximity of CL3 and CL8 leads to formation of the glibenclamide binding site.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418131     DOI: 10.1016/s0014-5793(01)02538-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Characterization of two novel forms of the rat sulphonylurea receptor SUR1A2 and SUR1BDelta31.

Authors:  Laurent Gros; Stefan Trapp; Michael Dabrowski; Frances M Ashcroft; Dominique Bataille; Philippe Blache
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.

Authors:  Frank Reimann; Michael Dabrowski; Phillippa Jones; Fiona M Gribble; Frances M Ashcroft
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

Review 3.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

Review 4.  Pannexin: from discovery to bedside in 11±4 years?

Authors:  Gerhard Dahl; Robert W Keane
Journal:  Brain Res       Date:  2012-07-04       Impact factor: 3.252

Review 5.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1.

Authors:  Michael V Mikhailov; Jeff D Campbell; Heidi de Wet; Kenju Shimomura; Brittany Zadek; Richard F Collins; Mark S P Sansom; Robert C Ford; Frances M Ashcroft
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

7.  Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity.

Authors:  Jie-Lin Pu; Bin Ye; Stacie L Kroboth; Elizabeth M McNally; Jonathan C Makielski; Nian-Qing Shi
Journal:  J Mol Cell Cardiol       Date:  2007-09-29       Impact factor: 5.000

8.  An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action.

Authors:  Diethart Schmid; Michael Stolzlechner; Albin Sorgner; Caterina Bentele; Alice Assinger; Peter Chiba; Thomas Moeslinger
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

9.  Two non-vesicular ATP release pathways in the mouse erythrocyte membrane.

Authors:  Feng Qiu; Junjie Wang; David C Spray; Eliana Scemes; Gerhard Dahl
Journal:  FEBS Lett       Date:  2011-10-01       Impact factor: 4.124

Review 10.  The bizarre pharmacology of the ATP release channel pannexin1.

Authors:  Gerhard Dahl; Feng Qiu; Junjie Wang
Journal:  Neuropharmacology       Date:  2013-03-13       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.